2015
Training in Infectious Disease Epidemiology through the Emerging Infections Program Sites - Volume 21, Number 9—September 2015 - Emerging Infectious Diseases journal - CDC
Vugia DJ, Meek JI, Danila RN, Jones TF, Schaffner W, Baumbach J, Lathrop S, Farley MM, Tobin-D'Angelo M, Miller L, Harrison LH, Bennett NM, Cieslak PR, Cartter ML, Reingold AL. Training in Infectious Disease Epidemiology through the Emerging Infections Program Sites - Volume 21, Number 9—September 2015 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2015, 21: 1516-1519. PMID: 26291924, PMCID: PMC4550163, DOI: 10.3201/eid2109.150443.Peer-Reviewed Original ResearchMeSH KeywordsCenters for Disease Control and Prevention, U.S.Communicable Diseases, EmergingEducationHumansPublic Health SurveillanceUnited StatesConceptsEmerging Infections ProgramInfectious disease epidemiologyInfectious Diseases journal - CDCHealth care partnersLocal health departmentsLocal public healthDisease epidemiologyInfectious disease surveillancePeer-reviewed journalsEpidemiologic projectInfections ProgramUS CentersEIP sitesHealth departmentsCare partnersDisease controlDisease surveillancePublic healthEpidemiologyConference presentationsTrainee projectsProgram's inceptionExtent of trainingPresentationTraining opportunitiesMonitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008–2012 - Volume 21, Number 9—September 2015 - Emerging Infectious Diseases journal - CDC
Hariri S, Markowitz LE, Bennett NM, Niccolai LM, Schafer S, Bloch K, Park IU, Scahill MW, Julian P, Abdullah N, Levine D, Whitney E, Unger ER, Steinau M, Bauer HM, Meek J, Hadler J, Sosa L, Powell SE, Johnson ML, Group H. Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008–2012 - Volume 21, Number 9—September 2015 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2015, 21: 1557-1561. PMID: 26291379, PMCID: PMC4550135, DOI: 10.3201/eid2109.141841.Peer-Reviewed Original ResearchConceptsHuman papillomavirus vaccineYears of agePapillomavirus vaccineEmerging Infections Program sitesPopulation-based surveillance systemActive population-based surveillanceInfectious Diseases journal - CDCPre-invasive cervical lesionsHPV vaccination historyHPV type distributionPopulation-based surveillanceCervical intraepithelial neoplasiaAcute infectious diseasesRelevant clinical informationCatchment area populationHPV vaccinationHPV typesVaccination historyIntraepithelial neoplasiaCervical cancerCervical lesionsVaccine introductionWomen 18Clinical informationUS populationEmerging Infections Program—State Health Department Perspective - Volume 21, Number 9—September 2015 - Emerging Infectious Diseases journal - CDC
Hadler JL, Danila RN, Cieslak PR, Meek JI, Schaffner W, Smith KE, Cartter ML, Harrison LH, Vugia DJ, Lynfield R. Emerging Infections Program—State Health Department Perspective - Volume 21, Number 9—September 2015 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2015, 21: 1510-1515. PMID: 26289952, PMCID: PMC4550133, DOI: 10.3201/eid2109.150428.Peer-Reviewed Original ResearchMeSH KeywordsCommunicable Disease ControlCommunicable Diseases, EmergingHumansInterinstitutional RelationsPublic Health SurveillanceState GovernmentUnited StatesConceptsEmerging Infections ProgramEIP sitesHealth departmentsDisease controlActive population-based surveillanceInfectious Diseases journal - CDCPopulation-based surveillanceState health departmentsPublic health challengeInfectious disease issuesPublic health programsInfections ProgramAcademic centersHealth programsHealth challengesPrevention fundsDepartment perspectiveDisease issuesDepartmentCenterPrevention
2013
Effectiveness of Nonadjuvanted Monovalent Influenza A(H1N1)pdm09 Vaccines for Preventing Reverse Transcription Polymerase Chain Reaction–Confirmed Pandemic Influenza Hospitalizations: Case-Control Study of Children and Adults at 10 US Influenza Surveillance Network Sites
Thompson M, Sokolow L, Almendares O, Openo K, Farley M, Meek J, Ray J, Kirley P, Reingold A, Aragon D, Hancock E, Baumbach J, Schaffner W, Thomas A, Lynfield R, Ryan P, Monroe M, Cheng P, Fry A, Shay D. Effectiveness of Nonadjuvanted Monovalent Influenza A(H1N1)pdm09 Vaccines for Preventing Reverse Transcription Polymerase Chain Reaction–Confirmed Pandemic Influenza Hospitalizations: Case-Control Study of Children and Adults at 10 US Influenza Surveillance Network Sites. Clinical Infectious Diseases 2013, 57: 1587-1592. PMID: 23956169, PMCID: PMC7314184, DOI: 10.1093/cid/cit551.Peer-Reviewed Original ResearchConceptsLaboratory-confirmed pandemic influenzaCommunity-matched controlsCase-control studyReverse transcription-polymerase chain reactionTranscription-polymerase chain reactionInfluenza hospitalizationsMonovalent influenzaPandemic influenzaSingle dosePolymerase chain reactionVirus infectionInfluenzaChain reactionHospitalizationVaccinePatientsInfectionDose